Adverse drug events, deaths soar

Are drug side effects getting worse, or are we just paying more attention? There's no denying the numbers have gone through the roof; according to new research from the Institute for Safe Medication Practices, the FDA received reports of 89,842 adverse events including 15,107 deaths in 2005, more than double the 1998 numbers of 34,966 reports and 5,519 deaths.

The increase isn't due to an increase in drugs--adverse events grew four times as fast as prescriptions--nor to the blockbuster-drugs-gone-bad like Vioxx and Bextra. It does relate to an increase in adverse reports from drug makers--not from doctors, who aren't required to report drug problems.

- check out this report on the findings
- read the article from the Wall Street Journal (sub. req.)

Related Articles:
Poll finds problems at the FDA. Report
FDA offers safety reforms to skeptical lawmakers. Report
IOM slams FDA, calls for major reforms. Report
Pharmacovigilance grows in importance. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.